AsclepiX Therapeutics
PrivateLast Round
Series A
Extension
Jul 26, 2023
Total Funding Raised
$61.2M
Company Overview
AsclepiX Therapeutics is a biopharmaceutical company focused on developing innovative and long-lasting treatments for retinal diseases through advanced computational biology and integrin-regulating peptides.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AsclepiX Therapeutics Comps
Public and private peers based on sector, stage, and business model.
AsclepiX Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jul 26, 2023 | ||||
| Series A | Jun 24, 2020 | ||||
| Convertible Debt | Nov 13, 2018 | ||||
| Grant | Nov 12, 2018 | ||||
| Convertible Debt | Jul 22, 2016 |
AsclepiX Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hibiscus BioVentures | Series A Extension |
| National Cancer Institute | Grant |
| Barer & Son Capital | Series A, Convertible Debt |
| Perceptive Advisors | Series A, Series A Extension |
| Research to Prevent Blindness | Grant |
| NIH RADx | Grant |
| Xontogeny | Series A |
AsclepiX Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AsclepiX Therapeutics's valuation, stock price, and market status.
